FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150562016> ?p ?o ?g. }

• W2150562016 endingPage "2220" @default.
• W2150562016 startingPage "2211" @default.
• W2150562016 abstract "Background— Doxorubicin (DOX) is an important antineoplastic agent. However, the associated cardiotoxicity, possibly mediated by the production of reactive oxygen species, has remained a significant and dose-limiting clinical problem. Our hypothesis is that the hematopoietic/megakaryocytopoietic growth factor thrombopoietin (TPO) protects against DOX-induced cardiotoxicity and might involve antiapoptotic mechanism exerted on cardiomyocytes. Methods and Results— In vitro investigations on H9C2 cell line and spontaneously beating cells of primary, neonatal rat ventricle, as well as an in vivo study in a mouse model of DOX-induced acute cardiomyopathy, were performed. Our results showed that pretreatment with TPO significantly increased viability of DOX-injured H9C2 cells and beating rates of neonatal myocytes, with effects similar to those of dexrazoxane, a clinically approved cardiac protective agent. TPO ameliorated DOX-induced apoptosis of H9C2 cells as demonstrated by assays of annexin V, active caspase-3, and mitochondrial membrane potential. In the mouse model, administration of TPO (12.5 μg/kg IP for 3 alternate days) significantly reduced DOX-induced (20 mg/kg) cardiotoxicity, including low blood cell count, cardiomyocyte lesions (apoptosis, vacuolization, and myofibrillar loss), and animal mortality. Using Doppler echocardiography, we observed increased heart rate, fractional shortening, and cardiac output in animals pretreated with TPO compared with those receiving DOX alone. Conclusions— These data have provided the first evidence that TPO is a protective agent against DOX-induced cardiac injury. We propose to further explore an integrated program, incorporating TPO with other protocols, for treatment of DOX-induced cardiotoxicity and other forms of cardiomyopathy." @default.
• W2150562016 created "2016-06-24" @default.
• W2150562016 creator A5002712013 @default.
• W2150562016 creator A5039608463 @default.
• W2150562016 creator A5046797812 @default.
• W2150562016 creator A5049823634 @default.
• W2150562016 creator A5050892306 @default.
• W2150562016 creator A5056769343 @default.
• W2150562016 creator A5062853635 @default.
• W2150562016 creator A5064375024 @default.
• W2150562016 creator A5065182329 @default.
• W2150562016 creator A5073949362 @default.
• W2150562016 creator A5074642572 @default.
• W2150562016 creator A5075289247 @default.
• W2150562016 creator A5079332858 @default.
• W2150562016 date "2006-05-09" @default.
• W2150562016 modified "2023-10-12" @default.
• W2150562016 title "Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin" @default.
• W2150562016 cites W1492360552 @default.
• W2150562016 cites W1963578253 @default.
• W2150562016 cites W1968351069 @default.
• W2150562016 cites W1979028006 @default.
• W2150562016 cites W1980502996 @default.
• W2150562016 cites W1983612778 @default.
• W2150562016 cites W1986021513 @default.
• W2150562016 cites W1992437129 @default.
• W2150562016 cites W2000536297 @default.
• W2150562016 cites W2003362694 @default.
• W2150562016 cites W2014063249 @default.
• W2150562016 cites W2043254982 @default.
• W2150562016 cites W2047530248 @default.
• W2150562016 cites W2051977557 @default.
• W2150562016 cites W2066323398 @default.
• W2150562016 cites W2070145271 @default.
• W2150562016 cites W2073189639 @default.
• W2150562016 cites W2073912429 @default.
• W2150562016 cites W2090816278 @default.
• W2150562016 cites W2098474355 @default.
• W2150562016 cites W2107401114 @default.
• W2150562016 cites W2108712459 @default.
• W2150562016 cites W2111340301 @default.
• W2150562016 cites W2116931750 @default.
• W2150562016 cites W2124086403 @default.
• W2150562016 cites W2159303243 @default.
• W2150562016 cites W2161082810 @default.
• W2150562016 cites W2162159710 @default.
• W2150562016 cites W2165681130 @default.
• W2150562016 cites W2279200935 @default.
• W2150562016 cites W2317912629 @default.
• W2150562016 cites W2326816074 @default.
• W2150562016 doi "https://doi.org/10.1161/circulationaha.105.560250" @default.
• W2150562016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16651473" @default.
• W2150562016 hasPublicationYear "2006" @default.
• W2150562016 type Work @default.
• W2150562016 sameAs 2150562016 @default.
• W2150562016 citedByCount "126" @default.
• W2150562016 countsByYear W21505620162012 @default.
• W2150562016 countsByYear W21505620162013 @default.
• W2150562016 countsByYear W21505620162014 @default.
• W2150562016 countsByYear W21505620162015 @default.
• W2150562016 countsByYear W21505620162016 @default.
• W2150562016 countsByYear W21505620162017 @default.
• W2150562016 countsByYear W21505620162018 @default.
• W2150562016 countsByYear W21505620162019 @default.
• W2150562016 countsByYear W21505620162020 @default.
• W2150562016 countsByYear W21505620162021 @default.
• W2150562016 countsByYear W21505620162022 @default.
• W2150562016 countsByYear W21505620162023 @default.
• W2150562016 crossrefType "journal-article" @default.
• W2150562016 hasAuthorship W2150562016A5002712013 @default.
• W2150562016 hasAuthorship W2150562016A5039608463 @default.
• W2150562016 hasAuthorship W2150562016A5046797812 @default.
• W2150562016 hasAuthorship W2150562016A5049823634 @default.
• W2150562016 hasAuthorship W2150562016A5050892306 @default.
• W2150562016 hasAuthorship W2150562016A5056769343 @default.
• W2150562016 hasAuthorship W2150562016A5062853635 @default.
• W2150562016 hasAuthorship W2150562016A5064375024 @default.
• W2150562016 hasAuthorship W2150562016A5065182329 @default.
• W2150562016 hasAuthorship W2150562016A5073949362 @default.
• W2150562016 hasAuthorship W2150562016A5074642572 @default.
• W2150562016 hasAuthorship W2150562016A5075289247 @default.
• W2150562016 hasAuthorship W2150562016A5079332858 @default.
• W2150562016 hasBestOaLocation W21505620161 @default.
• W2150562016 hasConcept C121608353 @default.
• W2150562016 hasConcept C126322002 @default.
• W2150562016 hasConcept C150903083 @default.
• W2150562016 hasConcept C190283241 @default.
• W2150562016 hasConcept C207001950 @default.
• W2150562016 hasConcept C207200792 @default.
• W2150562016 hasConcept C2776694085 @default.
• W2150562016 hasConcept C2776802502 @default.
• W2150562016 hasConcept C2778198053 @default.
• W2150562016 hasConcept C2778233292 @default.
• W2150562016 hasConcept C2778797674 @default.
• W2150562016 hasConcept C2779720357 @default.
• W2150562016 hasConcept C2781303535 @default.
• W2150562016 hasConcept C530470458 @default.
• W2150562016 hasConcept C55493867 @default.

• next